| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — |
| Net Income | $-1.0B | $16.1B | — | — | — | — |
| EPS (Basic) | — | — | — | — | — | — |
| EPS (Diluted) | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Total Assets | $14.5B | $19.2B | $26.4B | $10.5B | $29.6B | $17.7B |
| Current Assets | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — |
| Total Liabilities | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Current Liabilities | — | — | — | — | — | — |
| Stockholders' Equity | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.7B | $21.5B | — | — | — | — |
| Investing Cash Flow | — | — | — | — | — | — |
| Capital Expenditures | — | — | — | — | — | — |
| Financing Cash Flow | $-3.7B | $-21.5B | — | — | — | — |